Abstract:Dexamethasone as Treatment in Cerebrovascular Disease. 1.
A Controlled Study in Intracerebral Hemorrhage• Dexamethasone and a placebo were compared as treatment for 40 patients with intracerebral hemorrhage. Of 19 patients receiving dexamethasone, 17 (89.5%) died during their hospital admission. Of 21 patients receiving a placebo, 16 (76.2%) died. The mortality rate was 100% in 15 patients in the dexamethasone-treated group who were in coma or deep stupor on admission, and the mortality rate was 92% in 12 patients with similar levels of consciousness who received a placebo.Several parameters of the neurological examination showed an improved quality of survival in the Decadron®-treated group, but this was found only at certain days in the study. No overall statistically significant difference was found between the two therapies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.